Understanding Schizoaffective Disorder & Addiction
Schizoaffective disorder is a chronic mental health condition that combines features of schizophrenia (hallucinations, delusions, disorganized thinking) with significant mood episodes (major depressive or manic episodes). It is one of the most diagnostically complex and debilitating psychiatric conditions, affecting approximately 0.3% of the population. The dual nature of the illness -- psychotic symptoms occurring both during and independent of mood episodes -- creates a uniquely challenging clinical picture that significantly increases vulnerability to substance use disorders.
Individuals with schizoaffective disorder face an extraordinarily high rate of co-occurring substance use, with estimates ranging from 40% to 60%. Substances may be used to self-medicate distressing psychotic symptoms such as auditory hallucinations, to counteract the sedating effects of antipsychotic medications, to manage the depressive or manic mood episodes, or to cope with the social isolation and stigma associated with the diagnosis. Cannabis, alcohol, stimulants, and nicotine are the most commonly misused substances in this population. Substance use worsens the prognosis of schizoaffective disorder dramatically, increasing the frequency and severity of psychotic episodes, reducing medication adherence, and significantly elevating the risk of hospitalization, homelessness, and suicide.
At Trust SoCal, our dual diagnosis program provides specialized psychiatric care for schizoaffective disorder integrated with comprehensive addiction treatment. Our psychiatric team has expertise in managing the complex medication regimens required for schizoaffective disorder while simultaneously addressing substance use.